The SeriousTraders Newsletter

The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Newsletter Archives

SeriousTradersSpotlight Company

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

Investment Considerations NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multi-billion dollar unmet needs in central nervous system disorders. The company’s lead candidate, NRX-100 (preservative free IV ketamine), NDA in process with the FDA, has been granted Fast Track designation by the FDA for acute suicidal depression and a patent for this novel … Continue reading “NRx Pharmaceuticals Inc. (NASDAQ: NRXP)”

View Profile

NRx Pharmaceuticals Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}}
IBN (InvestorBrandNetwork)

SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:

CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SmallCapRelations (SCR)
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo